Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, potentially fatal, epileptic encephalopathy characterized by explosive-onset of recurrent multifocal and bilateral tonic-clonic seizures following an unspecific febrile illness. The syndrome develops without a clear acute structural, toxic or metabolic cause, in a patient without previous epilepsy. FIRES is a subgroup of new-onset refractory status epilepticus (NORSE), and requires a preceding febrile infection as a mandatory feature.
Biomarker and diagnostic research for febrile infection-related epilepsy syndrome has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
95 publications have been identified in PubMed for febrile infection-related epilepsy syndrome. Research spans Case Report / Case Series (33%), Epidemiology / Natural History (29%), and Review / Meta-Analysis (22%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 31 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 4:52 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression | 28 | 29% |
Research summaries | 21 | 22% |
Other research | 5 | 5% |
Clinical study results | 4 | 4% |
Testing and diagnosis research | 3 | 3% |
New treatment approaches | 2 | 2% |
Laboratory research | 1 | 1% |
Hommady R (2026). [PMID: 42035680](https://pubmed.ncbi.nlm.nih.gov/42035680/). *Seizure*. [Epidemiology / Natural History]
Azegami T (2026). [PMID: 42037319](https://pubmed.ncbi.nlm.nih.gov/42037319/). *Circ Popul Health Outcomes*. [Epidemiology / Natural History]
Nasuno M (2026). [PMID: 41707435](https://pubmed.ncbi.nlm.nih.gov/41707435/). *Brain Dev*. [Basic Science / Preclinical]
Peng J (2026). [PMID: 42227400](https://pubmed.ncbi.nlm.nih.gov/42227400/). *Curr Neuropharmacol*. [Review / Meta-Analysis]
Li R (2026). [PMID: 41767518](https://pubmed.ncbi.nlm.nih.gov/41767518/). *Front Med (Lausanne)*. [Epidemiology / Natural History]
Aoki H (2026). [PMID: 41232765](https://pubmed.ncbi.nlm.nih.gov/41232765/). *Can J Cardiol*. [Epidemiology / Natural History]
Okada K (2026). [PMID: 42070379](https://pubmed.ncbi.nlm.nih.gov/42070379/). *Brain Dev*. [Case Report / Case Series]
Chidambaram AC (2026). [PMID: 41679100](https://pubmed.ncbi.nlm.nih.gov/41679100/). *Seizure*. [Epidemiology / Natural History]
Nakayama T (2026). [PMID: 41881380](https://pubmed.ncbi.nlm.nih.gov/41881380/). *Am J Kidney Dis*. [Epidemiology / Natural History]
Masuda T (2026). [PMID: 42003621](https://pubmed.ncbi.nlm.nih.gov/42003621/). *J Am Heart Assoc*. [Epidemiology / Natural History]
AI-curated news mentioning febrile infection-related epilepsy syndrome
Updated Jun 9, 2026
A recent case report discusses the use of superfast vagus nerve stimulation (VNS) titration for treating super refractory status epilepticus (SRSE) in a pediatric patient during the acute phase of febrile infection-related epilepsy syndrome (FIRES). This study contributes to the understanding of VNS as a potential therapeutic option in acute settings.